Original Research
Published on 21 Jan 2022
Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis
in Cancer Immunity and Immunotherapy
![Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis](https://www.frontiersin.org/files/myhome article library/780191/780191_Thumb_400.jpg)
- 2,281 views
- 1 citation
Original Research
Published on 21 Jan 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Jan 2022
in Cancer Immunity and Immunotherapy
Review
Published on 14 Jan 2022
in Cancer Immunity and Immunotherapy
Case Report
Published on 13 Jan 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 12 Jan 2022
in Cancer Immunity and Immunotherapy
Review
Published on 12 Jan 2022
in Cancer Immunity and Immunotherapy
Case Report
Published on 10 Jan 2022
in Cancer Immunity and Immunotherapy
Perspective
Published on 10 Jan 2022
in Cancer Immunity and Immunotherapy
Review
Published on 07 Jan 2022
in Cancer Immunity and Immunotherapy
Review
Published on 06 Jan 2022
in Cancer Immunity and Immunotherapy
Review
Published on 05 Jan 2022
in Cancer Immunity and Immunotherapy
Correction
Published on 04 Jan 2022
in Cancer Immunity and Immunotherapy
Review
Published on 03 Jan 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 03 Jan 2022
in Cancer Immunity and Immunotherapy
Case Report
Published on 03 Jan 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 03 Jan 2022
in Cancer Immunity and Immunotherapy